| CAS Number: | 13826-94-3 |
| MDL Number: | MFCD00011376 |
| Molecular Formula: | Br4K2Pt |
| Molecular Weight: | 592.93 |
| Chemical Formula: | K2PtBr4 |
| Color and Form: | red pwdr. |
| Note: |
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Potassium tetrabromoplatinate(II), 99% |
| Product Number: | 78-1967 |
| CAS Registry Number: | 13826-94-3 |
| Formula: | K2PtBr4 |
| EINECS Number: | 237-536-1 |
| Chemical Family: | halometallate salt |
| Synonym: | Dipotassium tetrabromoplatinate, Potassium tetrabromoplatinate. |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title Compound | 13826-94-3 | 100 | 0.002mg/m3 | 0.002mg/m3 |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Irritating to skin, eyes and respiratory tract. |
| Primary Routes of Exposure: | Contact with skin and eyes. Inhalation of dust. |
| Eye Contact: | Causes mild irritation to the eyes. |
| Skin Contact: | Causes moderate irritation of the skin and dermatitis. Contact through a break in the skin can induce an allergic reaction. |
| Inhalation: | Inhalation of dust causes wheezing, coughing, shortness of breath and asthma like symptoms, typical of allergy. |
| Ingestion: | May cause nausea, vomiting dizziness, and abdominal pain and produce central nervous system effects. |
| Acute Health Effects: | Irritating to skin, eyes and respiratory tract. Symptoms of bromide ingestion may include skin rash, blurred vision, drowsiness, irritability, dizziness, mania, hallucinations, and coma. |
| Chronic Health Effects: | The chloroplatinate allergic reaction known as platinosis ceases when prolonged exposure is terminated. Prolonged exposure to bromides may cause skin rashes, memory loss, irritability, and headache. |
| NTP: | No |
| IARC: | No |
| OSHA: | No |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | not applicable |
| Autoignition Temperature: | none |
| Explosion Limits: | none |
| Extinguishing Medium: | None. Material is non-flammable. |
| Special Fire Fighting Procedures: | No special fire fighting procedures required. |
| Hazardous Combustion and Decomposion Products: | If involved in a fire this material may emit corrosive fumes of bromine |
| Unusual Fire or Explosion Hazards: | No unusual fire or explosion hazards. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | To avoid raising dust, small spills may be mixed with diatomaceous earth, sand, vermiculite or other suitable inert material and swept up. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store solid in a tightly sealed container. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear protective clothing and gloves. Consult with glove manufacturer to determine the proper type of glove. |
| Ventilation: | Material may form a fine dust. If possible, handle the material in an efficient fume hood. |
| Respirator: | If in form of fine dust and ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | red pwdr. |
| Molecular Weight: | 592.93 |
| Melting Point: | no data |
| Boiling Point: | no data |
| Vapor Pressure: | not applicable |
| Specific Gravity: | no data |
| Odor: | none |
| Solubility in Water: | very soluble |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | air and moisture stable |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | none |
| Incompatibility: | Active metals |
| Decomposition Products: | potassium bromide, platinum chlorides, platinum, and bromine. |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | Intraperitoneal (mouse); LDLo: 45 mg/kg. |
| Carcinogenic Effects: | no data |
| Mutagenic Effects: | no data |
| Tetratogenic Effects: | no data |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | No information available |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Non-hazardous |
| Hazard Class (CFR): | NA |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | NA |
| UN ID Number (CFR): | NA |
| Shipping Name (IATA): | Non-hazardous |
| Hazard Class (IATA): | NA |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | NA |
| UN ID Number (IATA): | NA |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Listed in the TSCA inventory. |
| SARA (Title 313): | Title compound not listed. |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 1/02/2004 |
| Revision Date: | 7/29/2011 |